Understand how LH and FSH fit with testosterone results, why normal-range values need context and how fertility goals shape the clinical discussion.
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are hormones released by the pituitary gland that send different signals to the testes. LH supports testosterone production. FSH supports sperm production.
Both belong to a group called gonadotropins. They form part of the hypothalamic-pituitary-gonadal system, the signaling network linking the brain and testes. They are not different names for testosterone.
The European Association of Urology (EAU) recommends measuring LH and FSH to help distinguish types of hypogonadism, the clinical syndrome of testosterone deficiency. Testosterone measurement helps establish whether testosterone is low. LH and FSH help clinicians understand the signaling pattern behind that result.
These roles explain why a hormone panel contains more than one measurement. Understanding how testosterone is produced within the testes provides useful background for interpreting the signals that support that process.
This article is for informational purposes and is not medical advice. A qualified clinician should interpret individual results and make decisions about further testing or treatment.
An LH or FSH result described as high, low or within range needs to be considered alongside testosterone. These categories describe the signaling hormone result. They do not independently establish whether a man has testosterone deficiency or explain its cause.
The biological question is whether the signals reaching the testes are appropriate for the testosterone result. This is why a within-range result is not automatically reassuring when testosterone is low.
The EAU describes several patterns that help clinicians make this distinction.
Low testosterone with high gonadotropins can point toward primary hypogonadism, meaning impaired testicular function. In this pattern, the testosterone result is low despite increased hormonal signaling.
The important finding is the combination. High LH considered alone is not equivalent to low testosterone with high LH. Keeping the paired results together helps prevent a laboratory flag from becoming a diagnosis by itself.
The EAU describes low or inappropriately normal gonadotropins alongside low testosterone as characteristic of secondary hypogonadism. Here, stimulation from the hypothalamic-pituitary system is inadequate.
“Inappropriately normal” means that a result can sit within its reference interval yet still be inadequate in the context of low testosterone. The issue is not simply whether the laboratory marks the number as abnormal. It is whether the signaling pattern fits the accompanying testosterone level.
This is the main reason that a normal-range LH or FSH result should not end the discussion when testosterone is low.
The EAU describes elevated LH with normal testosterone as a compensated or subclinical pattern. It states that the clinical significance of this pattern is unclear.
This belongs in a different category from low testosterone with high gonadotropins. The testosterone result remains essential to the interpretation. A high LH flag should not be translated into a claim of established testicular failure.
The EAU recommends morning, fasting testosterone testing. When testosterone is below its stated threshold of 12 nmol/L, it recommends confirmation on at least two separate occasions.
That threshold applies to testosterone. It is not an LH or FSH reference limit and should not be transferred to those measurements.
Confirmation also serves a different purpose from LH and FSH testing. Repeat testosterone measurements help establish the biochemical finding. Gonadotropin measurements help classify the associated signaling pattern.
For more background on that distinction, see why testosterone evaluation can involve repeated blood draws.
The EAU recommends measuring LH with prolactin when pathological testosterone levels are found. It also identifies pituitary imaging in specified cases of secondary hypogonadism.
These are parts of a clinician-directed evaluation. A low or within-range gonadotropin result does not, by itself, establish a specific pituitary condition or determine whether imaging is appropriate.
For adult men, the clinical presentation matters as much as the laboratory pattern. The EAU defines hypogonadism through symptoms or signs together with biochemical evidence of testosterone deficiency. LH and FSH help classify that picture rather than replace it.
Symptoms alone do not identify which gonadotropin pattern is present. Likewise, a hormone pattern does not supply a complete explanation for a man's concerns. The useful discussion connects what he is experiencing with confirmed testosterone results and the accompanying signals.
This keeps two questions separate: whether testosterone deficiency is present and what may explain it. A person’s symptoms belong in the first discussion. LH and FSH contribute to the second.
Fertility adds another clinical concern. FSH supports sperm production, so its interpretation is relevant when a man is being evaluated for reproductive difficulties.
The EAU male-infertility guideline notes that FSH generally correlates negatively with spermatogonial numbers. In plain language, higher FSH generally goes with fewer spermatogonia. That association does not turn an FSH result into a precise measurement of sperm count.
A testosterone discussion and a fertility discussion therefore overlap without being interchangeable. Men whose concern includes having children should make that goal explicit during the evaluation, even if the appointment began with a question about testosterone.
The evidence here identifies several physiological influences on LH and FSH interpretation. These concern the source of hormonal stimulation, testicular function and the effects of testosterone treatment.
The distinction between the first two patterns is not merely a change in terminology. It separates a problem involving testicular function from one involving inadequate hormonal stimulation. That distinction can influence the clinician's further evaluation and fertility discussion.
According to the EAU guideline, testosterone therapy is contraindicated for men seeking fertility because it suppresses sperm production. A treatment intended to address testosterone deficiency should not be assumed to support reproduction.
This is especially important when a man sees low testosterone as the main problem and assumes that adding testosterone would also help sperm production. The guideline identifies suppression of gonadotropins and spermatogenesis as a reason fertility goals belong in the discussion before therapy begins.
The EAU also says gonadotropin treatment may be used to restore fertility in men with secondary hypogonadism. This is a specialist treatment consideration tied to the underlying condition, not a general recommendation for every man with low testosterone.
Understanding the fertility trade-offs associated with testosterone treatment helps explain why reproductive goals affect the clinical conversation. The relevant decision is not simply whether a testosterone number should increase. It also includes which biological process is impaired and whether having children is a goal.
Ask: “Are my LH and FSH appropriate for my testosterone level? Does this pattern suggest impaired testicular function or inadequate central signaling? Does my testosterone result need confirmation or further evaluation? How do my fertility goals affect the discussion?”
An LH or FSH flag can distract from the relationship between hormone signals and testicular function, which Testostra addresses through clear biomarker explanations. Its coverage helps men distinguish total testosterone from free testosterone and understand SHBG while keeping the discussion educational rather than diagnostic.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra